Anti-SSEA-4 MicroBeads have been developed for the positive selection or depletion of SSEA-4+ pluripotent or tissue stem cells.
Related products for Anti-SSEA-4 MicroBeads, human
Anti-SSEA-4 MicroBeads have been developed for the positive selection or depletion of SSEA-4+ pluripotent or tissue stem cells.
Stage-specific embryonic antigen 4 (SSEA-4) is a glycolipid epitope that is found on undifferentiated human embryonic stem (ES) cells1, induced pluripotent (iPS) cells2 embryonal carcinoma (EC) cells3, and embryonic germ (EG)4 cells and a variety of somatic stem cells, such as dental pulp stem cells, umbilical cord blood-derived very small embryonic like stem cells (VSELs)5 and mesenchymal stromal cells6.
For positive selection: LS or autoMACS® Columns. For depletion: LD or autoMACS Columns.
SSEA-4 expressing cells were isolated from a heterogeneous suspension of U937 cells (SSEA-4–CD326–) and NTERA cells (SSEA-4+CD326+) using Anti-SSEA-4 MicroBeads, an LS Column, and a MidiMACS Separator. Cells were fluorescently stained with Labeling Check Reagent-FITC and CD326 (EpCAM)-APC. Cell debris and dead cells were excluded based on scatter signals and propidium iodide fluorescence.
- Valamehr, B. et al. (2012) A novel platform to enable the high-throughput derivation and characterization of feeder-free human iPSCs. Sci Rep 2: 213
- Kannagi, R. et al. (1983) Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside. EMBO J. 2 (12): 2355-2361
- Bhartiya, D. et al. (2012) Very small embryonic-like stem cells with maximum regenerative potential get discarded during cord blood banking and bone marrow processing for autologous stem cell therapy. Stem Cells Dev. 21: 1-6
- Thomson, J. A. et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147
- Shamblott, M. J. et al. (1999) Proc. Natl. Acad. Sci. U.S.A. 95: 13726-13731
- D'Ippolito, G. et al. (2006) Sustained stromal stem cell self-renewal and osteoblastic differentiation during aging. Rejuvenation Res. 9: 10-19
You have previously chosen International as your location.
What do you want to do?